BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$9.09B
1-Year Return
13.74%
This Quarter Return
+1.38%
1 Year Return
+13.74%
3 Year Return
+18.18%
5 Year Return
–
10 Year Return
–
AUM
$994M
AUM Growth
+$657M
(+195%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
57.64%
Top 10 Holdings %
Top 10 Hldgs %
27.43%
Holding
1,069
New
718
Increased
187
Reduced
44
Closed
85
Top Buys
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$101M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$38.7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$24.8M |
| 4 |
Home Depot
HD
|
+$14.9M |
| 5 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$11.5M |
Top Sells
| 1 |
iShares MSCI Brazil ETF
EWZ
|
+$33.3M |
| 2 |
CME Group
CME
|
+$20.5M |
| 3 |
Moderna
MRNA
|
+$16.2M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$12.4M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$7.07M |
Sector Composition
| 1 | Technology | 14.22% |
| 2 | Industrials | 10.54% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Financials | 8.32% |
| 5 | Healthcare | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Independent Bank
INDB
$3.47B
| $262K | ﹤0.01% |
+3,980
| New | +$262K |
|
727
Oxford Industries
OXM
$601M
| $261K | ﹤0.01% |
+2,610
| New | +$261K |
|
728
MSC Industrial Direct
MSM
$5.11B
| $261K | ﹤0.01% |
+2,575
| New | +$261K |
|
729
Brown & Brown
BRO
$30.5B
| $260K | ﹤0.01% |
+3,656
| New | +$260K |
|
730
Apellis Pharmaceuticals
APLS
$3.3B
| $260K | ﹤0.01% |
+4,343
| New | +$260K |
|
731
Cousins Properties
CUZ
$4.9B
| $259K | ﹤0.01% |
+10,649
| New | +$259K |
|
732
Toro Company
TTC
$7.7B
| $257K | ﹤0.01% |
+2,677
| New | +$257K |
|
733
Dana Inc
DAN
$2.72B
| $256K | ﹤0.01% |
+17,526
| New | +$256K |
|
|
CSW
734
CSW Industrials, Inc.
CSW
$4.25B
| $256K | ﹤0.01% |
+1,233
| New | +$256K |
|
735
Arcosa
ACA
$4.72B
| $253K | ﹤0.01% |
+3,062
| New | +$253K |
|
736
Evercore
EVR
$12.8B
| $252K | ﹤0.01% |
+1,475
| New | +$252K |
|
737
James River Group
JRVR
$247M
| $252K | ﹤0.01% |
+27,281
| New | +$252K |
|
738
Compass
COMP
$4.84B
| $252K | ﹤0.01% |
66,927
+39,273
| +142% | +$148K |
|
739
Merus
MRUS
$5.11B
| $251K | ﹤0.01% |
+9,134
| New | +$251K |
|
740
Mettler-Toledo International
MTD
$25.9B
| $251K | ﹤0.01% |
207
-109
| -34% | -$132K |
|
741
Prudential Financial
PRU
$37.2B
| $251K | ﹤0.01% |
+2,419
| New | +$251K |
|
742
Eaton
ETN
$141B
| $250K | ﹤0.01% |
+1,040
| New | +$250K |
|
743
Medpace
MEDP
$13.4B
| $250K | ﹤0.01% |
+814
| New | +$250K |
|
744
Altice USA
ATUS
$1.09B
| $249K | ﹤0.01% |
76,747
+62,182
| +427% | +$202K |
|
745
Afya
AFYA
$1.38B
| $249K | ﹤0.01% |
+11,347
| New | +$249K |
|
|
ITOS
746
DELISTED
iTeos Therapeutics
ITOS
| $249K | ﹤0.01% |
+22,705
| New | +$249K |
|
747
8x8 Inc
EGHT
$284M
| $246K | ﹤0.01% |
65,093
+53,635
| +468% | +$203K |
|
748
RLI Corp
RLI
$6.08B
| $246K | ﹤0.01% |
+3,696
| New | +$246K |
|
749
The Ensign Group
ENSG
$9.59B
| $246K | ﹤0.01% |
+2,192
| New | +$246K |
|
750
Coherus Oncology, Inc. Common Stock
CHRS
$151M
| $245K | ﹤0.01% |
73,562
+62,110
| +542% | +$207K |
|